FilingReader Intelligence

Tianmao Group faces delisting risk amid delayed financial reports

July 1, 2025 at 05:18 PM UTCBy FilingReader AI

Tianmao Group [SZSE:000627] is facing potential delisting risks as it has failed to disclose its 2024 annual report by the July 1st deadline. Trading in Tianmao Group shares has been suspended since May 6, 2025, as the company could not release its annual reports by the April 30 deadline. If the company fails to release the report within two months of this suspension, the Shenzhen Stock Exchange will implement a delisting risk warning. The company cites the need for further verification and refinement of information as the reason for the delay. The company has also received notice from the China Securities Regulatory Commission regarding alleged failure to disclose periodic reports on schedule.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Hubei Biocause Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →